In newly issued guidelines, the American Gastroenterological Association did not recommend using probiotics for most digestive conditions.
The society said there was insufficient evidence to make recommendations on the use of probiotics to treat Clostridioides difficile infection, Crohn’s disease, ulcerative colitis or irritable bowel syndrome. If patients with any of these conditions are taking probiotics, the AGA suggested that they stop due to associated costs and lack of evidence concerning potential harm.
The AGA recommended specific antibiotic strains for each suggested treatment. It is important for patients to remember that not all probiotic strains are the same, and even different strains of the same species can have very different effects.
Gastroenterologists should suggest the use of probiotics to their patients only if there is clear benefit and should recognize that the effects of probiotics are not species-specific, but strain- and combination-specific.
About the society:
The American Gastroenterological Association (AGA) is the trusted voice of the GI community. Founded in 1897, AGA has grown to include more than 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology.
Note: This list is a brief compilation of some of the key recommendations included in the Guideline and is not exhaustive and does not constitute medical advice. Original guideline is attached as pdf.